PAA 7.32% 22.0¢ pharmaust limited

Pfizer

  1. 1,516 Posts.
    lightbulb Created with Sketch. 630
    Does Pfizer's CoVid-19 vaccination strong hopeful with early data signals strengthen or weaken the company's development of a vaccine also? It is a huge job vaccinating the globe in due course and I would not be alone in saying that that there would be room for other branding hopefuls who have capabilities of becoming successful under the right circumstances. Remember Kalkine Media reported that both MPL and MPLS treatments reduces up to approx 95% CoV-2 virus particles in cell culture.

    PAA is a minnow with many strings to its bow in the environment of multi billion dollar parmaceuticals and would would become a highly priced share in any successful development and manufacturing happening.
    Their cancer research is also outstanding. Don't give up on them. Dyor.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.015(7.32%)
Mkt cap ! $87.1M
Open High Low Value Volume
21.0¢ 22.0¢ 21.0¢ $134.7K 629.2K

Buyers (Bids)

No. Vol. Price($)
2 24563 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 64222 3
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
21.5¢
  Change
0.015 ( 2.38 %)
Open High Low Volume
21.0¢ 22.0¢ 21.0¢ 340156
Last updated 15.57pm 07/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.